| Primary |
| Asthma |
41.8% |
| Drug Use For Unknown Indication |
21.8% |
| Chronic Obstructive Pulmonary Disease |
10.9% |
| Sinusitis |
5.5% |
| Product Used For Unknown Indication |
3.6% |
| Status Asthmaticus |
3.6% |
| Arthralgia |
1.8% |
| Atrial Fibrillation |
1.8% |
| Cough |
1.8% |
| Hypersensitivity |
1.8% |
| Lung Disorder |
1.8% |
| Mastocytosis |
1.8% |
| Nasal Polyps |
1.8% |
|
| Aspartate Aminotransferase Increased |
9.4% |
| Hepatic Enzyme Increased |
9.4% |
| Alanine Aminotransferase Increased |
6.3% |
| Renal Failure Acute |
6.3% |
| Serum Ferritin Increased |
6.3% |
| Tachycardia |
6.3% |
| Unevaluable Event |
6.3% |
| Viral Infection |
6.3% |
| Wheezing |
6.3% |
| White Blood Cell Count Decreased |
6.3% |
| Abnormal Dreams |
3.1% |
| Anaphylactic Reaction |
3.1% |
| Cardiomyopathy |
3.1% |
| Completed Suicide |
3.1% |
| Death |
3.1% |
| Dilatation Ventricular |
3.1% |
| Hallucination |
3.1% |
| Hepatitis |
3.1% |
| Infectious Mononucleosis |
3.1% |
| Liver Function Test Abnormal |
3.1% |
|
| Secondary |
| Asthma |
43.5% |
| Fibromyalgia |
15.2% |
| Seasonal Allergy |
15.2% |
| Migraine |
13.0% |
| Drug Use For Unknown Indication |
6.5% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Eye Pruritus |
2.2% |
| Sinusitis |
2.2% |
|
| Sinusitis |
28.6% |
| Blood Pressure Increased |
14.3% |
| Cataract |
14.3% |
| Hepatotoxicity |
14.3% |
| Pharmaceutical Product Complaint |
14.3% |
| Sensitivity Of Teeth |
14.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
41.1% |
| Asthma |
23.3% |
| Product Used For Unknown Indication |
14.7% |
| Hypersensitivity |
6.7% |
| Incision Site Pain |
1.8% |
| Hypertension |
1.7% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Infection |
1.2% |
| Pregnancy |
1.2% |
| Blood Immunoglobulin G Decreased |
0.9% |
| Sinus Headache |
0.9% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
| Pain |
0.8% |
| Depression |
0.7% |
| Osteoporosis |
0.6% |
| Angina Pectoris |
0.4% |
| Coronary Artery Disease |
0.4% |
| Hormone Replacement Therapy |
0.4% |
| Multiple Myeloma |
0.4% |
| Myasthenia Gravis |
0.4% |
|
| Wheezing |
13.6% |
| Urticaria |
12.5% |
| Drug Exposure During Pregnancy |
10.2% |
| Status Asthmaticus |
5.7% |
| Throat Tightness |
5.7% |
| Asthma |
4.5% |
| Blood Pressure Increased |
4.5% |
| Thrombosis |
4.5% |
| Chest Discomfort |
3.4% |
| Hypotension |
3.4% |
| Loss Of Consciousness |
3.4% |
| Pharyngeal Oedema |
3.4% |
| Product Quality Issue |
3.4% |
| Pulmonary Embolism |
3.4% |
| Rash |
3.4% |
| Respiratory Distress |
3.4% |
| Speech Disorder |
3.4% |
| Vomiting |
3.4% |
| Cardiomegaly |
2.3% |
| Drug Ineffective |
2.3% |
|
